logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Daisuke Kotani

Department of Gastrointestinal Oncology
H指数:26
被引数:4,070

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal ctDNA profiling to guide anti-EGFR rechallenge in metastatic colorectal cancer: a prospective single-arm phase II trial

纵向ctDNA分析指导抗EGFR再挑战治疗在转移性结直肠癌中的应用：一项前瞻性单臂II期临床试验

Communications Medicine
IF6.3
2026-09-090
OAAI
Yoshinori Kagawa; Daisuke Kotani; Hiroya Taniguchi; Tadayoshi Hashimoto; Hideaki Bando; Naoki Takahashi; Tetsuya Hamaguchi; Akiyoshi Kanazawa; Takeshi Kato; Koji Ando; Hisateru Yasui; Eiji Shinozaki; Yu Sunakawa; Atsuo Takashima; Kentaro Yamazaki; Satoshi Yuki; Yoshiaki Nakamura; Masashi Wakabayashi; Hiromichi Nakajima; Takashi Ohta; Takayuki Yoshino
Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer

WES定义的ERBB2扩增在可切除结直肠癌中的临床意义

International Journal of Clinical Oncology
IF2.8
2026-08-200
OAAI
Kazuki Kishi; Atsushi Hamabe; Yusuke Suwa; Naoya Akazawa; Keiji Hirata; Masataka Ikeda; Mitsuru Yokota; Kentaro Kato; Masahito Kotaka; Yujiro Nishizawa; Hideaki Bando; Yoshiaki Nakamura; Saori Mishima; Tadayoshi Hashimoto; Arkarachai Fungtammasan; Charuta C. Palsuledesai; Robert W. Lentz; Daisuke Kotani; Hiroya Taniguchi; Jun Watanabe; Ichiro Takemasa; Takeshi Kato; Mamoru Uemura; Hidetoshi Eguchi; Yuichiro Doki; Eiji Oki; Takayuki Yoshino
Gut microbial and metabolic biomarkers for early-onset colorectal cancer

肠道微生物和代谢生物标志物用于早发性结直肠癌

Microbiome
IF12.7
2026-08-080
OA
Balqis Arche Nofinska; Sayaka Mizutani; Felix Salim; Hironori Sunakawa; Nozomu Obana; Satoshi Shiba; Kensuke Shinmura; Daisuke Kotani; Tatsuo Yachida; Hiroyuki Takamaru; Akihito Kawazoe; Yutaka Saito; Hiroaki Ikematsu; Shinji Fukuda; Shinichi Yachida; Takuji Yamada
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial

ctDNA阳性的结直肠癌患者术后辅助化疗: 一项随机3期试验

Nature Medicine
IF50
2026-06-080
OAAI
Hideaki Bando; Jun Watanabe; Yusuke Takahashi; Masahito Kotaka; Nobuhisa Matsuhashi; Eiji Oki; Yoshito Komatsu; Manabu Shiozawa; Keiji Hirata; Yuji Miyamoto; Masanobu Takahashi; Kentaro Yamazaki; Dai Manaka; Akiyoshi Kanazawa; Yi-Hsin Liang; Kun-Huei Yeh; Yuko Watsuji; Yuko Yamamoto; Makoto Fukui; Shruti Sharma; Vasily N. Aushev; Adham Jurdi; Matthew Rabinowitz; Minetta C. Liu; Alexey Aleshin; Ichiro Takemasa; Daisuke Kotani; Akihiro Sato; Toshihiro Misumi; Yoshiaki Nakamura; Qian Shi; Hiroya Taniguchi; Takayuki Yoshino; Takeshi Kato
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery A Prospective Cohort Study: Erratum

直肠癌症患者接受根治性手术后的分子残留病灶与复发：前瞻性队列研究：勘误

Annals of Surgery
IF6.4
2026-04-090
PRE
Ando, Koji; Hamabe, Atsushi; Nakamura, Yoshiaki; Watanabe, Jun; Hirata, Keiji; Kataoka, Kozo; Miyo, Masaaki; Kato, Kentaro; Akazawa, Naoya; Kagawa, Yoshinori; Yokota, Mitsuru; Yamazaki, Kentaro; Mishima, Saori; Yukami, Hiroki; Kotani, Daisuke; Bando, Hideaki; Laliotis, George; Sharma, Shruti; Palsuledesai, Charuta C.; Rabinowitz, Matthew; Jurdi, Adham; Liu, Minetta C.; Aleshin, Alexey; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Yoshino, Takayuki; Oki, Eiji
Real-world outcomes of encorafenib, cetuximab ± binimetinib for BRAF‑mutated metastatic colorectal cancer: The BEETS (JACCRO CC‑18) study

encorafenib、cetuximab ± binimetinib治疗BRAF突变型转移性结直肠癌的真实世界疗效：BEETS（JACCRO CC-18）研究

The Oncologist
IF0
2026-02-270
OA
Daisuke Kotani; Eisuke Inoue; Tadamichi Denda; Chiaki Inagaki; Tomomi Kashiwada; Yoshiaki Mihara; Akinori Sugaya; Yusuke Suwa; Takashi Ohta; Hidekazu Kuramochi; Kotoe Oshima; Satoshi Yuki; Manabu Shiozawa; Akihito Tsuji; Kei Muro; Wataru Ichikawa; Masashi Fujii; Yu Sunakawa
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study

来自GALAXY研究的结直肠癌患者中基于甲基化的无组织MRD测定的验证

npj Precision Oncology
IF8
2026-01-190
OAAI
Yoshiaki Nakamura; Johannes G. Reiter; Prashanthi Natarajan; Joshua Babiarz; Preethi Srinivasan; Jayashree Joshi; Yu Lin; Tzu-Chun Chen; Nathan Liang; Su Maw; Ehsan Haghshenas; Garima Kushwaha; Boris Gutman; Ilker Tunc; Wen-Ching Chan; Antony Tin; Yuefan Huang; Sara L. Bristow; Meenakshi Malhotra; Shruti Sharma; Stephanie A. Sanchez; Adham Jurdi; Minetta C. Liu; Trupti Kawli; Matthew Rabinowitz; Alexey Aleshin; Daisuke Kotani; Oki Eiji; Takayuki Yoshino
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)

一项关于厄洛替尼用于BRAF V600E突变型转移性结直肠癌的多中心II期研究：BRAVERY研究（EPOC1701）

ESMO Open
IF8.3
2025-10-090
OAAI
T. Masuishi; H. Taniguchi; D. Kotani; H. Bando; Y. Komatsu; E. Shinozaki; Y. Sunakawa; T. Satoh; T. Nishina; T. Esaki; M. Wakabayashi; S. Nomura; K. Takahashi; H. Ono; N. Hirano; N. Fujishiro; N. Fuse; A. Sato; Y. Sakamoto; N. Kuramoto; I. Miki; H. Ichiki; Y. Nakamura; G. Sharma; S. Skrzypczak; E. Schultz; C. Kingsford; A. Ohtsu; T. Yoshino
Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer

CLDN18.2阳性胃癌患者接受含zolbetuximab化疗期间早期胃炎的特征分析

ESMO Open
IF8.3
2025-09-300
OAAI
K. Yamamoto; Y. Owaki; I. Nakayama; N. Sakamoto; M. Ishizaka; T. Kadota; D. Okemoto; Y. Matsubara; Y. Miyashita; A. Kobayashi; U. Okazaki; K. Seguchi; T. Hosokai; T. Ogura; S. Mishima; D. Kotani; A. Kawazoe; T. Hashimoto; Y. Kuboki; H. Bando; T. Kojima; T. Yoshino; T. Kuwata; G. Ishii; T. Yano; K. Shitara
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study

分子残留病灶及复发在行术前手术的直肠癌患者中的研究：一项前瞻性队列研究

Annals of Surgery
IF6.4
2025-09-260
OAAI
Ando, Koji MD, PhD; Hamabe, Atsushi MD, PhD; Nakamura, Yoshiaki MD, PhD; Watanabe, Jun MD, PhD; Hirata, Keiji MD, PhD; Kataoka, Kozo MD, PhD; Miyo, Masaaki MD, PhD; Kato, Kentaro MD; Akazawa, Naoya MD; Kagawa, Yoshinori MD, PhD; Yokota, Mitsuru MD, PhD; Yamazaki, Kentaro MD, PhD; Mishima, Saori MD, PhD; Yukami, Hiroki MD; Kotani, Daisuke MD, PhD; Bando, Hideaki MD, PhD; Laliotis, George MD, MHA, MPH, MBA; Sharma, Shruti PhD; Palsuledesai, Charuta C. PhD; Rabinowitz, Matthew PhD; Jurdi, Adham MD; Liu, Minetta C. MD; Aleshin, Alexey MD; Taniguchi, Hiroya MD, PhD; Takemasa, Ichiro MD, PhD; Kato, Takeshi MD, PhD; Yoshino, Takayuki MD, PhD; Oki, Eiji MD, PhD
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer

Claudin 18.2 表达对 HER2 阴性、 proficient MMR、PD-L1 CPS ⩾1 转移性胃/胃食管结合部癌患者一线免疫化疗治疗结局的影响

Therapeutic Advances in Medical Oncology
IF4.2
2025-09-200
OA
Fei Zhang; Izuma Nakayama; Naoya Sakamoto; Dai Okemoto; Amane Jubashi; Yuki Matsubara; Yu Miyashita; Seiya Sato; Shinpei Ushiyama; Akinori Kobayashi; Ukyo Okazaki; Kazumasa Yamamoto; Saori Mishima; Daisuke Kotani; Akihito Kawazoe; Tadayoshi Hashimoto; Yoshiaki Nakamura; Yasutoshi Kuboki; Hideaki Bando; Takashi Kojima; Takayuki Yoshino; Takeshi Kuwata; Kohei Shitara
Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan

fruquintinib在难治性转移性结直肠癌患者中的疗效和安全性：日本入组患者FRESCO-2亚组分析

international journal of oncology
IF2.8
2025-09-010
OAAI
Daisuke Kotani; Takayuki Yoshino; Toshiki Masuishi; Yu Sunakawa; Atsuo Takashima; Kentaro Yamazaki; Hisato Kawakami; Tomohiro Nishina; Yoshito Komatsu; Taito Esaki; Cathy Eng; Stacey Ukrainskyj; Rajash Pallai; Shivani Nanda; Zhao Yang; William Schelman; Marek Kania; Taroh Satoh
HIBRID: histology-based risk-stratification with deep learning and ctDNA in colorectal cancer

HIBRID：基于组织学的结直肠癌风险分层，结合深度学习和ctDNA

Nature Communications
IF15.7
2025-08-140
OAAI
Chiara M. L. Loeffler; Hideaki Bando; Srividhya Sainath; Hannah Sophie Muti; Xiaofeng Jiang; Marko van Treeck; Nic Gabriel Reitsam; Zunamys I. Carrero; Asier Rabasco Meneghetti; Tomomi Nishikawa; Toshihiro Misumi; Saori Mishima; Daisuke Kotani; Hiroya Taniguchi; Ichiro Takemasa; Takeshi Kato; Eiji Oki; Yuan Tanwei; Wankhede Durgesh; Sebastian Foersch; Hermann Brenner; Michael Hoffmeister; Yoshiaki Nakamura; Takayuki Yoshino; Jakob Nikolas Kather
A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901)

一项使用ASP-1929联合纳武利尤单抗治疗晚期胃癌的光免疫疗法Ib期研究（GE-PIT, EPOC1901）

GASTRIC CANCER
IF5.1
2025-05-150
PRE
Tomohiro Kadota; Rika Fujii; Shohei Koyama; Daisuke Kotani; Yusuke Yoda; Miki Fukutani; Mitsuko Suzuki; Masashi Wakabayashi; Takashi Ikeno; Hironori Sunakawa; Yoshiaki Nakamura; Akihito Kawazoe; Takuma Irie; Nozomu Fuse; Akihiro Sato; Tomonori Yano; Kohei Shitara
Factors responsible for the decline in physical fitness during neoadjuvant chemotherapy in older patients with esophageal cancer: an exploratory prospective cohort study

老年食管癌患者新辅助化疗期间体能下降的影响因素：一项探索性前瞻性队列研究

SUPPORTIVE CARE IN CANCER
IF3
2025-04-280
PRE
Harada, Tsuyoshi; Tsuji, Tetsuya; Ueno, Junya; Konishi, Nobuko; Yanagisawa, Takumi; Hijikata, Nanako; Ishikawa, Aiko; Hashimoto, Kakeru; Kagaya, Hitoshi; Tatematsu, Noriatsu; Zenda, Sadamoto; Kotani, Daisuke; Kojima, Takashi; Fujita, Takeo
Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancer

曲妥珠单抗deruxtecan治疗HER2-positive胃癌或胃食管交界处癌的疗效和安全性的预后和预测因素

GASTRIC CANCER
IF5.1
2024-11-020
OAAI
Jubashi, Amane; Nakayama, Izuma; Koganemaru, Shigehiro; Sakamoto, Naoya; Oda, Shioto; Matsubara, Yuki; Miyashita, Yu; Sato, Seiya; Ushiyama, Shinpei; Kobayashi, Akinori; Okazaki, Ukyo; Okemoto, Dai; Yamamoto, Kazumasa; Mishima, Saori; Kotani, Daisuke; Kawazoe, Akihito; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Kuboki, Yasutoshi; Bando, Hideaki; Kojima, Takashi; Yoshino, Takayuki; Miyaaki, Hisamitsu; Nakao, Kazuhiko; Shitara, Kohei
ctDNA-based molecular residual disease and survival in resectable colorectal cancer

可切除结直肠癌中基于ctDNA的分子残留疾病和生存

NATURE MEDICINE
IF50
2024-09-161
OAAI
Nakamura, Yoshiaki; Watanabe, Jun; Akazawa, Naoya; Hirata, Keiji; Kataoka, Kozo; Yokota, Mitsuru; Kato, Kentaro; Kotaka, Masahito; Kagawa, Yoshinori; Yeh, Kun-Huei; Mishima, Saori; Yukami, Hiroki; Ando, Koji; Miyo, Masaaki; Misumi, Toshihiro; Yamazaki, Kentaro; Ebi, Hiromichi; Okita, Kenji; Hamabe, Atsushi; Sokuoka, Hiroki; Kobayashi, Satoshi; Laliotis, George; Aushev, Vasily N.; Sharma, Shruti; Jurdi, Adham; Liu, Minetta C.; Aleshin, Alexey; Rabinowitz, Matthew; Bando, Hideaki; Taniguchi, Hiroya; Takemasa, Ichiro; Kato, Takeshi; Kotani, Daisuke; Mori, Masaki; Yoshino, Takayuki; Oki, Eiji
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC

Quattro-ii随机试验: CAPOXIRI bevacizumab与FOLFOXIRI bevacizumab作为mCRC患者的一线治疗

MED
IF11.8
2024-09-010
OA
Bando, Hideaki; Kotani, Daisuke; Satake, Hironaga; Hamaguchi, Tetsuya; Shiozawa, Manabu; Kotaka, Masahito; Masuishi, Toshiki; Yasui, Hisateru; Kagawa, Yoshinori; Komatsu, Yoshito; Oki, Eiji; Yamamoto, Yoshiyuki; Kawakami, Hisato; Misumi, Toshihiro; Taniguchi, Hiroya; Yamazaki, Kentaro; Muro, Kei; Yoshino, Takayuki; Kato, Takeshi; Tsuji, Akihito

研究方向

暂未获取到该数据
T
Takayuki Yoshino
H 指数:88论文数:1,566被引数:4.9万
H
Hideaki Bando
H 指数:42论文数:595被引数:7,335
Y
Yoshiaki Nakamura
H 指数:40论文数:669被引数:9,240
H
Hiroya Taniguchi
H 指数:36论文数:433被引数:7,594
T
Takashi Kojima
H 指数:47论文数:360被引数:1.1万
K
Kohei Shitara
H 指数:79论文数:1,129被引数:3.5万
T
Takeshi Kato
H 指数:49论文数:664被引数:7,878
S
Saori Mishima
H 指数:19论文数:139被引数:2,142
A
Akihito Kawazoe
H 指数:38论文数:380被引数:9,315
Y
Yoshito Komatsu
H 指数:54论文数:829被引数:1.5万